arrow_back Back to App

Support for Brain and Nervous System Disease Research

This act establishes a new center and advisory group to accelerate the development of drugs and therapies for brain and nervous system diseases. This aims to bring effective treatments faster to millions suffering from neurological and mental conditions, improving their quality of life.
Key points
Creation of a Neuroscience Center of Excellence to focus on research and development of brain disease treatments.
Establishment of a Neuroscience Translation Working Group to advise on turning scientific discoveries into approved therapies.
Allocation of $25 million annually for 2023-2027 to support these efforts, potentially speeding up access to new medications.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_HR_5435
Sponsor: Rep. Blumenauer, Earl [D-OR-3]
Process start date: 2021-09-30
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

BRAIN Act of 2021

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HR_5435.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2021-09-30.

What are the main provisions?

Key points include:

  • Creation of a Neuroscience Center of Excellence to focus on research and development of brain disease treatments.
  • Establishment of a Neuroscience Translation Working Group to advise on turning scientific discoveries into approved therapies.
  • Allocation of $25 million annually for 2023-2027 to support these efforts, potentially speeding up access to new medications.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Blumenauer, Earl [D-OR-3].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-28.

CATEGORIES

Health